Beta2-adrenergic receptor — Drug Target

All drugs that target Beta2-adrenergic receptor — marketed and clinical-stage. Includes 9 drug classes acting on this target.

Drug classes

Corticosteroid/long-acting beta2-adrenergic receptor agonist · Corticosteroid and long-acting beta2-adrenergic receptor agonist combination · Long-acting beta2-adrenergic receptor agonist · Inhaled corticosteroid/long-acting beta2-adrenergic agonist · Long-acting beta2-agonist (LABA) · Long-acting beta2-adrenergic receptor agonist/inhaled corticosteroid combination · Inhaled corticosteroid and long-acting beta2-adrenergic receptor agonist combination · LABA · Long-acting beta2-adrenergic receptor agonist (LABA)

Phase 3 pipeline (11)

• Spiromax Budesonide/formoterol · University Medical Center Groningen · Corticosteroid/long-acting beta2-adrenergic receptor agonist · Respiratory
  Spiromax Budesonide/formoterol is a combination of a corticosteroid and a long-acting beta2-adrenergic receptor agonist used to treat asthma and COPD.
• Symbicort TBH - Turbuhaler · AstraZeneca · Corticosteroid and long-acting beta2-adrenergic receptor agonist combination · Respiratory
  Symbicort TBH is a combination of budesonide and formoterol, a corticosteroid and a long-acting beta2-adrenergic receptor agonist, respectively, used to control symptoms of asthma and COPD.
• levalbuterol tartrate MDI · Sumitomo Pharma America, Inc. · Long-acting beta2-adrenergic receptor agonist · Respiratory
  Levalbuterol tartrate is a long-acting beta2-adrenergic receptor agonist that works by relaxing bronchial muscles to improve airflow to the lungs.
• Symbicort Turbohaler · Pearl Therapeutics, Inc. · Corticosteroid and long-acting beta2-adrenergic receptor agonist combination · Respiratory
  Symbicort Turbohaler is a combination of budesonide and formoterol, a corticosteroid and a long-acting beta2-adrenergic receptor agonist, respectively, used to control symptoms of asthma and chronic obstructive pulmonary disease (COPD).
• Symbicort® Turbohaler® Inhalation Powder · Pearl Therapeutics, Inc. · Inhaled corticosteroid/long-acting beta2-adrenergic agonist · Respiratory
  Symbicort is a combination of budesonide, an inhaled corticosteroid, and formoterol, a long-acting beta2-adrenergic agonist, used to control symptoms of asthma and chronic obstructive pulmonary disease (COPD).
• Seretide Evohaler · FLUIDDA nv · Corticosteroid and long-acting beta2-adrenergic receptor agonist combination · Respiratory
  Seretide Evohaler is a combination of fluticasone and salmeterol, which work together to reduce inflammation and bronchospasm in the airways.
• long-acting beta2-agonist · National Heart, Lung, and Blood Institute (NHLBI) · Long-acting beta2-agonist (LABA) · Respiratory
  Long-acting beta2-agonists bind to beta2-adrenergic receptors on airway smooth muscle, causing prolonged relaxation and bronchodilation.
• Salmeterol/Fluticasone propionate combination product · GlaxoSmithKline · Long-acting beta2-adrenergic receptor agonist/inhaled corticosteroid combination · Respiratory
  Salmeterol/Fluticasone propionate combination product is a long-acting beta2-adrenergic receptor agonist/inhaled corticosteroid combination that works by relaxing airway muscles and reducing inflammation in the lungs.
• Symbicort Turbuhaler · Orion Corporation, Orion Pharma · Inhaled corticosteroid and long-acting beta2-adrenergic receptor agonist combination · Respiratory
  Symbicort Turbuhaler is a combination of budesonide, an inhaled corticosteroid, and formoterol, a long-acting beta2-adrenergic receptor agonist, used to control symptoms of asthma and chronic obstructive pulmonary disease (COPD).
• indacaterol maleate/mometasone furoate · Novartis · Long-acting beta2-adrenergic receptor agonist/inhaled corticosteroid combination · Respiratory
  Indacaterol maleate is a long-acting beta2-adrenergic receptor agonist, while mometasone furoate is an inhaled corticosteroid.
• budesonide plus formoterol combination · Chiesi Farmaceutici S.p.A. · Corticosteroid and long-acting beta2-adrenergic receptor agonist combination · Respiratory
  Budesonide is a corticosteroid that reduces inflammation, while formoterol is a long-acting beta2-adrenergic receptor agonist that relaxes airway muscles.

Phase 2 pipeline (4)

• Inhaled LABA use · GlaxoSmithKline · Long-acting beta2-adrenergic receptor agonist · Respiratory
  Long-acting beta2-adrenergic receptor agonist
• Foradil P 24µg · MEDA Pharma GmbH & Co. KG · LABA · Respiratory
  Foradil P 24µg is a long-acting beta2-adrenergic receptor agonist (LABA) used to control and prevent bronchospasm in patients with asthma and COPD.
• Foradil Aerolizer, High Dose · AstraZeneca · Long-acting beta2-adrenergic receptor agonist (LABA) · Respiratory
  beta2-adrenergic receptor agonist
• Foradil Aerolizer, Low Dose · AstraZeneca · Long-acting beta2-adrenergic receptor agonist · Respiratory
  Foradil Aerolizer, a low-dose form of the drug, is a long-acting beta2-adrenergic receptor agonist that helps to open airways in the lungs.